Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume 32, Issue 1, Pages 1-9
Publisher
Wiley
Online
2013-03-20
DOI
10.1002/hon.2046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences
- (2016) Xavier Thomas Expert Opinion on Drug Discovery
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
- (2012) A. Quintas-Cardama et al. BLOOD
- Acute myeloid leukemia in the real world: why population-based registries are needed
- (2012) G. Juliusson et al. BLOOD
- The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML
- (2012) Alan K. Burnett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment of Unfit Patients With Acute Myeloid Leukemia: A Still Open Clinical Challenge
- (2012) Felicetto Ferrara Clinical Lymphoma Myeloma & Leukemia
- Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
- (2012) B. Deschler et al. HAEMATOLOGICA
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Acute myeloid leukemia in older adults
- (2012) Masamitsu Yanada et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
- (2012) Krzysztof Mrózek et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemtuzumab Ozogamicin: Time to Resurrect?
- (2012) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
- (2012) Stefan Faderl et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
- (2012) A K Burnett et al. LEUKEMIA
- Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients
- (2011) U. Brunnberg et al. ANNALS OF ONCOLOGY
- Applicability of a "Pick a Winner" trial design to acute myeloid leukemia
- (2011) R. K. Hills et al. BLOOD
- Acute myeloid leukaemia in the elderly: a review
- (2011) Daniel A. Pollyea et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly
- (2011) Felicetto Ferrara et al. CANCER
- Azacitidine for the treatment of patients with acute myeloid leukemia
- (2011) Luca Maurillo et al. CANCER
- A Network Meta-analysis of Randomized Controlled Trials of Induction Treatments in Acute Myeloid Leukemia in the Elderly
- (2011) Dimitrios C. Ziogas et al. CLINICAL THERAPEUTICS
- Induction and postremission strategies in acute myeloid leukemia: what is new?
- (2011) Yishai Ofran et al. CURRENT OPINION IN HEMATOLOGY
- Chromatin modifying agents – the cutting edge of anticancer therapy
- (2011) Faith A.A. Kwa et al. DRUG DISCOVERY TODAY
- A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
- (2011) M. Lubbert et al. HAEMATOLOGICA
- Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience
- (2011) Murat Ozbalak et al. HEMATOLOGICAL ONCOLOGY
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
- (2011) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
- (2011) A K Burnett et al. LEUKEMIA
- Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
- (2011) D A Pollyea et al. LEUKEMIA
- New Prognostic Markers in Acute Myeloid Leukemia: Perspective from the Clinic
- (2011) J. M. Foran Hematology-American Society of Hematology Education Program
- Has there been progress in the treatment of older patients with acute myeloid leukemia?
- (2010) Harry P. Erba BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
- (2010) B. Lowenberg et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Farnesyltransferase inhibitors: where are we now?
- (2010) Apostolia Maria Tsimberidou et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- European Development of Clofarabine as Treatment for Older Patients With Acute Myeloid Leukemia Considered Unsuitable for Intensive Chemotherapy
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
- (2010) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study
- (2010) Cecile Pautas et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of older patients with acute myeloid leukaemia
- (2010) Felicetto Ferrara LANCET
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
- (2010) W. Blum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
- (2009) J.-L. Harousseau et al. BLOOD
- The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial
- (2009) Alan K. Burnett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clofarabine: emerging role in leukemias
- (2009) Keeran Sampat et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors
- (2009) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
- (2009) Lanlan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
- (2009) Amanda F. Cashen et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
- (2009) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- What is the role of reduced-intensity transplantation in the treatment of older patients with AML?
- (2009) S. J. Forman Hematology-American Society of Hematology Education Program
- Vulnerable and frail elderly: An approach to the management of the main tumour types
- (2008) Silvio Monfardini et al. EUROPEAN JOURNAL OF CANCER
- Clinically useful prognostic factors in acute myeloid leukemia
- (2007) Felicetto Ferrara et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started